16:06 ATHN AthenaHealth beats by $0.10, beats on revs; reaffirms FY14 EPS guidance, revs guidance (127.78 -2.75)
Reports Q2 (Jun) earnings of $0.32 per share, excluding non-recurring items, $0.10 better than the Capital IQ Consensus Estimate of $0.22; revenues rose 27.1% year/year to $185.9 mln vs the $181.98 mln consensus.
Co reaffirms guidance for FY14, sees EPS of $0.98-1.10, excluding non-recurring items, vs. $1.04 Capital IQ Consensus Estimate; sees FY14 revs of $725-755 mln vs. $741.85 mln Capital IQ Consensus Estimate.
For the three months ended June 30, 2014, Non-GAAP Adjusted Operating Income was $21.6 mln, or 11.6% of total revenue, compared to Non-GAAP Adjusted Operating Income of $11.2 mln, or 7.6% of total revenue, in the same period last year. |
